SCHEMBL104076

SCHEMBL104076

[CH2]CNC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28150480 0.95
SCHEMBL6477542 0.69
SCHEMBL82444 0.67
Dimethylamine SCHEMBL28330971 0.67
Dimethylamine SCHEMBL27842114 0.63
SCHEMBL592710 0.63
Methylethylamine SCHEMBL14666 0.59
SCHEMBL310119 0.59
SCHEMBL14716928 0.59 CARM1 (0.47)
SCHEMBL2781835 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12006 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121802-B1 HIGH REFRACTIVE INDEX SILOXANE INSERT MATERIALS FOR EMBEDDED CONTACT LENSES ALCON INC (CH) 2024-07-17 EP claimed
US-20240190891-A1 PYRIDO OXAZINE AMINO DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2024-06-13 US claimed
EP-4076916-B1 WETTABLE SILICONE HYDROGEL CONTACT LENSES ALCON INC (CH) 2024-06-12 EP claimed
WO-2024114793-A1 SALT FORM AND CRYSTAL FORM OF UBIQUITINATION-SPECIFIC PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州普济远成生物医药科技有限公司 2024-06-06 WO claimed
US-11999676-B2 Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2024-06-04 US claimed
US-11999879-B2 Adhesive film and display member comprising the same SAMSUNG SDI CO., LTD. (KR) 2024-06-04 US claimed
CN-118121608-A Ubiquitin specific protease inhibitor salt form, ubiquitin specific protease inhibitor crystal form, preparation methods and application of ubiquitin specific protease inhibitor salt form and ubiquitin specific protease inhibitor crystal form 杭州普济远成生物医药科技有限公司 2024-06-04 CN claimed
EP-4373835-A1 MACROCYLIC IMMUNOMODULATORS Bristol-Myers Squibb Company (US) 2024-05-29 EP claimed
CN-118084864-A PRMT4 inhibitor, and pharmaceutical composition, pharmaceutical preparation and application thereof 北京福元医药股份有限公司 2024-05-28 CN claimed
EP-4369081-A2 METHOD FOR PRODUCING AN OPHTHALMIC PRODUCT Alcon Inc. (CH) 2024-05-15 EP claimed
EP-0030092-A1 Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1981-06-10 EP claimed
US-4267319-A CATIONIC DYES AND N-HETEROCYCLIC CATIONIC POLYMERS; PRINTING PAPER; ORANGE OR RED BASF AKTIENGESELLSCHAFT (DE) 1981-05-12 US claimed
EP-0000889-B1 3\"-N-DEMETHYL-3\"-N-SUBSTITUTED-4,6-DI-0-(AMINOGLYCOSYL)-1,3-DIAMINOCYCLITOLS, METHODS FOR THEIR PREPARATION AND THEIR APPLICATION AS ANTIBIOTICS BAYER AG (DE) 1981-04-29 EP claimed
EP-0010418-A1 Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP claimed
US-4107432-A ANTIBIOTICS MERCK & CO., INC. (US) 1978-08-15 US claimed
US-4058661-A 7-Diacyl cephalosporins MERCK & CO., INC. (US) 1977-11-15 US claimed
US-4053286-A ACYLATION MERCK & CO., INC. (US) 1977-10-11 US claimed
US-4014873-A Process for the production of 7-acylamidocephalosporins MERCK & CO., INC. (US) 1977-03-29 US claimed
US-3980677-A Anthraquinone dyestuffs containing sulphonic acid groups BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US claimed
US-3933800-A O-SUBSTITUTED OXIMES, MICROBIOCIDES GRUPPO LEPETIT S.P.A. (IT) 1976-01-20 US claimed